Zhenghui Gordon Jiang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis | 13 | 2024 | 1892 | 1.820 |
Why?
|
Apolipoproteins B | 9 | 2021 | 385 | 1.480 |
Why?
|
Hepatitis, Alcoholic | 2 | 2021 | 109 | 1.390 |
Why?
|
Lipoproteins, VLDL | 6 | 2018 | 201 | 1.280 |
Why?
|
Elasticity Imaging Techniques | 4 | 2021 | 383 | 1.270 |
Why?
|
Adenosine Deaminase | 3 | 2021 | 247 | 1.210 |
Why?
|
Lipoproteins | 3 | 2021 | 884 | 1.140 |
Why?
|
Pyrophosphatases | 2 | 2021 | 140 | 1.010 |
Why?
|
Apyrase | 6 | 2019 | 369 | 0.920 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1649 | 0.830 |
Why?
|
Fatty Liver | 4 | 2024 | 753 | 0.790 |
Why?
|
Liver Diseases, Alcoholic | 3 | 2024 | 156 | 0.780 |
Why?
|
Lipoproteins, HDL | 3 | 2021 | 661 | 0.780 |
Why?
|
Kupffer Cells | 1 | 2021 | 143 | 0.760 |
Why?
|
Autocrine Communication | 1 | 2021 | 169 | 0.740 |
Why?
|
Paracrine Communication | 1 | 2021 | 275 | 0.700 |
Why?
|
End Stage Liver Disease | 2 | 2021 | 334 | 0.700 |
Why?
|
Basal Metabolism | 1 | 2021 | 161 | 0.690 |
Why?
|
Liver | 8 | 2024 | 7426 | 0.610 |
Why?
|
Hepatorenal Syndrome | 1 | 2018 | 68 | 0.570 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2017 | 31 | 0.570 |
Why?
|
Aspartate Aminotransferases | 3 | 2019 | 412 | 0.560 |
Why?
|
Serum | 1 | 2017 | 212 | 0.540 |
Why?
|
Adenosine Triphosphatases | 2 | 2017 | 833 | 0.540 |
Why?
|
Mastocytosis, Systemic | 1 | 2018 | 102 | 0.540 |
Why?
|
Lipase | 1 | 2018 | 325 | 0.520 |
Why?
|
Liver Failure | 1 | 2018 | 247 | 0.520 |
Why?
|
Alanine Transaminase | 3 | 2019 | 603 | 0.510 |
Why?
|
Antigens, CD | 6 | 2024 | 3908 | 0.490 |
Why?
|
Enteric Nervous System | 1 | 2017 | 203 | 0.470 |
Why?
|
Nutrition Surveys | 7 | 2021 | 1697 | 0.470 |
Why?
|
Triglycerides | 5 | 2015 | 2469 | 0.470 |
Why?
|
Aspirin | 2 | 2016 | 3341 | 0.460 |
Why?
|
Gene Deletion | 1 | 2021 | 2665 | 0.430 |
Why?
|
Cell-Derived Microparticles | 1 | 2014 | 161 | 0.420 |
Why?
|
Colonoscopy | 2 | 2019 | 1377 | 0.420 |
Why?
|
Monocytes | 1 | 2021 | 2556 | 0.410 |
Why?
|
Models, Molecular | 8 | 2014 | 5385 | 0.380 |
Why?
|
Alcoholism | 1 | 2021 | 1936 | 0.370 |
Why?
|
Lipids | 1 | 2021 | 3329 | 0.360 |
Why?
|
Liver Diseases | 1 | 2019 | 1276 | 0.360 |
Why?
|
Colon | 1 | 2017 | 1780 | 0.330 |
Why?
|
Egg Proteins, Dietary | 2 | 2006 | 6 | 0.330 |
Why?
|
Colitis | 1 | 2017 | 1216 | 0.320 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1970 | 0.290 |
Why?
|
Hepatic Encephalopathy | 3 | 2018 | 143 | 0.290 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1815 | 0.290 |
Why?
|
Protein Structure, Tertiary | 11 | 2014 | 3786 | 0.290 |
Why?
|
Keratin-18 | 2 | 2016 | 40 | 0.260 |
Why?
|
Cholangitis, Sclerosing | 2 | 2019 | 177 | 0.260 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2266 | 0.260 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 2422 | 0.250 |
Why?
|
Macrophages | 4 | 2019 | 5693 | 0.250 |
Why?
|
Microfilament Proteins | 3 | 2009 | 1133 | 0.240 |
Why?
|
Crohn Disease | 1 | 2017 | 2255 | 0.240 |
Why?
|
Blood Proteins | 2 | 2009 | 1155 | 0.240 |
Why?
|
Cholesterol, LDL | 1 | 2014 | 2407 | 0.230 |
Why?
|
Trypsin | 1 | 2005 | 494 | 0.230 |
Why?
|
Cholesterol | 3 | 2021 | 2904 | 0.230 |
Why?
|
Egg Proteins | 3 | 2010 | 57 | 0.220 |
Why?
|
Lipoproteins, LDL | 3 | 2018 | 641 | 0.220 |
Why?
|
Apolipoprotein C-III | 2 | 2017 | 209 | 0.210 |
Why?
|
Obesity | 2 | 2021 | 12806 | 0.200 |
Why?
|
Insulin Resistance | 1 | 2015 | 3913 | 0.200 |
Why?
|
Portal Vein | 1 | 2024 | 427 | 0.190 |
Why?
|
Membrane Proteins | 1 | 2018 | 7808 | 0.190 |
Why?
|
Mitochondria, Liver | 1 | 2021 | 186 | 0.190 |
Why?
|
Protein Folding | 4 | 2009 | 843 | 0.190 |
Why?
|
Humans | 49 | 2024 | 752411 | 0.180 |
Why?
|
Phosphoproteins | 2 | 2009 | 2424 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2021 | 255 | 0.180 |
Why?
|
Acetyltransferases | 1 | 2021 | 228 | 0.180 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 2750 | 0.180 |
Why?
|
Male | 28 | 2024 | 354908 | 0.180 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1026 | 0.180 |
Why?
|
Middle Aged | 21 | 2024 | 217039 | 0.180 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3755 | 0.170 |
Why?
|
Cross-Sectional Studies | 7 | 2018 | 25539 | 0.170 |
Why?
|
Protein Structure, Secondary | 5 | 2014 | 1226 | 0.160 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15680 | 0.160 |
Why?
|
Adult | 16 | 2021 | 216927 | 0.160 |
Why?
|
Inflammation | 3 | 2023 | 10696 | 0.160 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2019 | 126 | 0.160 |
Why?
|
Female | 24 | 2024 | 386085 | 0.150 |
Why?
|
Adipose Tissue, White | 1 | 2021 | 363 | 0.150 |
Why?
|
Ascites | 2 | 2018 | 338 | 0.150 |
Why?
|
Coffee | 1 | 2021 | 582 | 0.140 |
Why?
|
Lipoprotein(a) | 1 | 2021 | 494 | 0.140 |
Why?
|
Chromatography, Gel | 2 | 2014 | 642 | 0.140 |
Why?
|
Dextran Sulfate | 1 | 2017 | 252 | 0.140 |
Why?
|
Pancreatitis | 1 | 2023 | 1098 | 0.140 |
Why?
|
Mutation, Missense | 3 | 2011 | 2556 | 0.130 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 21717 | 0.130 |
Why?
|
Hepatitis, Chronic | 1 | 2016 | 52 | 0.130 |
Why?
|
Liver Regeneration | 1 | 2017 | 213 | 0.130 |
Why?
|
Defecation | 1 | 2017 | 189 | 0.130 |
Why?
|
Animals, Genetically Modified | 1 | 2021 | 1553 | 0.130 |
Why?
|
Circular Dichroism | 2 | 2007 | 344 | 0.130 |
Why?
|
Factor VII | 1 | 2015 | 139 | 0.130 |
Why?
|
Teaching Rounds | 1 | 2019 | 275 | 0.130 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 757 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1278 | 0.120 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2016 | 95 | 0.120 |
Why?
|
Ammonia | 1 | 2015 | 235 | 0.120 |
Why?
|
Hyperammonemia | 1 | 2015 | 78 | 0.120 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 800 | 0.120 |
Why?
|
Liver Function Tests | 1 | 2015 | 524 | 0.110 |
Why?
|
Hepatitis, Autoimmune | 1 | 2016 | 167 | 0.110 |
Why?
|
Purines | 1 | 2017 | 600 | 0.110 |
Why?
|
Insulin-Secreting Cells | 1 | 2021 | 895 | 0.110 |
Why?
|
Adenosine Diphosphate | 1 | 2014 | 427 | 0.110 |
Why?
|
United States | 7 | 2021 | 71438 | 0.110 |
Why?
|
Anthropometry | 1 | 2017 | 1342 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 780 | 0.100 |
Why?
|
Neutrophils | 1 | 2024 | 3724 | 0.100 |
Why?
|
Mice, Knockout | 4 | 2024 | 14297 | 0.100 |
Why?
|
Apolipoproteins E | 1 | 2017 | 1431 | 0.100 |
Why?
|
ROC Curve | 2 | 2016 | 3532 | 0.090 |
Why?
|
Feces | 1 | 2017 | 1438 | 0.090 |
Why?
|
Animals | 11 | 2024 | 166811 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6501 | 0.090 |
Why?
|
Aged | 10 | 2024 | 166585 | 0.090 |
Why?
|
Blotting, Western | 2 | 2016 | 5035 | 0.090 |
Why?
|
Colectomy | 1 | 2015 | 671 | 0.090 |
Why?
|
Apolipoproteins C | 1 | 2010 | 59 | 0.090 |
Why?
|
Lipid Metabolism Disorders | 1 | 2010 | 20 | 0.090 |
Why?
|
Prospective Studies | 3 | 2021 | 53809 | 0.090 |
Why?
|
Phosphatidylcholines | 2 | 2014 | 406 | 0.090 |
Why?
|
Homeostasis | 1 | 2021 | 3277 | 0.090 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 3 | 2009 | 510 | 0.080 |
Why?
|
Th17 Cells | 1 | 2016 | 776 | 0.080 |
Why?
|
Antiviral Agents | 2 | 2019 | 3031 | 0.080 |
Why?
|
Adenoma | 1 | 2019 | 2141 | 0.080 |
Why?
|
Fasting | 1 | 2015 | 1590 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2480 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2021 | 3990 | 0.080 |
Why?
|
Mice | 6 | 2024 | 80550 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4652 | 0.080 |
Why?
|
Models, Chemical | 2 | 2007 | 611 | 0.080 |
Why?
|
Cell-Free System | 1 | 2008 | 338 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12138 | 0.080 |
Why?
|
Hypobetalipoproteinemias | 1 | 2007 | 11 | 0.070 |
Why?
|
Dimyristoylphosphatidylcholine | 1 | 2007 | 26 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2016 | 5838 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12745 | 0.070 |
Why?
|
Chylomicrons | 1 | 2006 | 26 | 0.070 |
Why?
|
Apolipoprotein B-100 | 1 | 2007 | 154 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2269 | 0.070 |
Why?
|
Genotype | 2 | 2018 | 12869 | 0.070 |
Why?
|
Gelsolin | 1 | 2007 | 189 | 0.070 |
Why?
|
Atherosclerosis | 2 | 2017 | 3503 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2400 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6331 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2018 | 2236 | 0.070 |
Why?
|
Insulin | 1 | 2021 | 6569 | 0.070 |
Why?
|
Carrier Proteins | 3 | 2010 | 4931 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12901 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5859 | 0.060 |
Why?
|
Kidney | 1 | 2021 | 6984 | 0.060 |
Why?
|
Protein Biosynthesis | 2 | 2014 | 2110 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3859 | 0.060 |
Why?
|
Spodoptera | 1 | 2005 | 141 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 6955 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 17958 | 0.060 |
Why?
|
Young Adult | 5 | 2018 | 57632 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15508 | 0.060 |
Why?
|
Glycosylation | 1 | 2017 | 1086 | 0.060 |
Why?
|
Peptide Fragments | 2 | 2009 | 5070 | 0.060 |
Why?
|
Time Factors | 3 | 2021 | 39846 | 0.060 |
Why?
|
Fimbriae, Bacterial | 1 | 2004 | 137 | 0.060 |
Why?
|
Phosphorylation | 2 | 2024 | 8315 | 0.060 |
Why?
|
Hydrolysis | 1 | 2005 | 666 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3806 | 0.060 |
Why?
|
Ketone Bodies | 1 | 2023 | 76 | 0.060 |
Why?
|
Biophysics | 1 | 2005 | 380 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4271 | 0.060 |
Why?
|
Bacterial Adhesion | 1 | 2004 | 307 | 0.050 |
Why?
|
Actins | 2 | 2009 | 2048 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1911 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2018 | 4117 | 0.050 |
Why?
|
Kinetics | 2 | 2010 | 6352 | 0.050 |
Why?
|
Amino Acids | 1 | 2009 | 1713 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1689 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9898 | 0.050 |
Why?
|
Granulocytes | 1 | 2024 | 551 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2404 | 0.050 |
Why?
|
Motion | 1 | 2006 | 782 | 0.050 |
Why?
|
Cross-Linking Reagents | 1 | 2005 | 687 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7747 | 0.050 |
Why?
|
Protein Binding | 3 | 2010 | 9273 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 3288 | 0.050 |
Why?
|
Toll-Like Receptor 4 | 1 | 2024 | 572 | 0.050 |
Why?
|
Prognosis | 1 | 2021 | 29337 | 0.050 |
Why?
|
Acetylation | 1 | 2023 | 1047 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2006 | 1119 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2008 | 1894 | 0.040 |
Why?
|
Tea | 1 | 2021 | 283 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 240 | 0.040 |
Why?
|
Registries | 1 | 2016 | 8367 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6792 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 21851 | 0.040 |
Why?
|
Escherichia coli | 3 | 2009 | 4184 | 0.040 |
Why?
|
Transfection | 1 | 2017 | 5780 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 293 | 0.040 |
Why?
|
Risk Factors | 4 | 2024 | 73425 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11729 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13405 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15647 | 0.040 |
Why?
|
Up-Regulation | 1 | 2017 | 4114 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 649 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2017 | 4220 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2014 | 13410 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58299 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15622 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 12796 | 0.040 |
Why?
|
Israel | 1 | 2019 | 711 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1006 | 0.040 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17591 | 0.040 |
Why?
|
Caffeine | 1 | 2021 | 697 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4571 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17647 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1952 | 0.030 |
Why?
|
Beverages | 1 | 2021 | 817 | 0.030 |
Why?
|
Glycoproteins | 1 | 2023 | 2195 | 0.030 |
Why?
|
Receptor, Adenosine A2A | 1 | 2016 | 128 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1953 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 765 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21157 | 0.030 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2016 | 201 | 0.030 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2017 | 214 | 0.030 |
Why?
|
Ileostomy | 1 | 2015 | 118 | 0.030 |
Why?
|
Triolein | 1 | 2014 | 9 | 0.030 |
Why?
|
Attitude | 1 | 2019 | 772 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 237 | 0.030 |
Why?
|
Calcium | 1 | 2007 | 5699 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23234 | 0.030 |
Why?
|
Platelet Activation | 1 | 2017 | 657 | 0.030 |
Why?
|
Dietary Fiber | 1 | 2017 | 757 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2024 | 79133 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 621 | 0.030 |
Why?
|
Necrosis | 1 | 2017 | 1601 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7212 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2824 | 0.030 |
Why?
|
Biological Transport | 1 | 2017 | 2073 | 0.030 |
Why?
|
Exosomes | 1 | 2017 | 422 | 0.030 |
Why?
|
Adenosine | 1 | 2017 | 825 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2711 | 0.030 |
Why?
|
Adolescent | 2 | 2017 | 86766 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1496 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12449 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7400 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 977 | 0.030 |
Why?
|
Length of Stay | 2 | 2016 | 6372 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3285 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1614 | 0.020 |
Why?
|
Microsomes, Liver | 1 | 2011 | 176 | 0.020 |
Why?
|
Rats | 1 | 2017 | 23563 | 0.020 |
Why?
|
Surface Properties | 1 | 2014 | 1154 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2017 | 10360 | 0.020 |
Why?
|
Hepacivirus | 1 | 2018 | 1329 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4058 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1485 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2011 | 531 | 0.020 |
Why?
|
Lipoproteins, IDL | 1 | 2010 | 18 | 0.020 |
Why?
|
Steroids | 1 | 2015 | 921 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8443 | 0.020 |
Why?
|
Brefeldin A | 1 | 2010 | 68 | 0.020 |
Why?
|
Reference Values | 1 | 2017 | 4898 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2318 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2016 | 886 | 0.020 |
Why?
|
Microsomes | 1 | 2010 | 252 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2499 | 0.020 |
Why?
|
Viscoelastic Substances | 1 | 2009 | 20 | 0.020 |
Why?
|
Buffers | 1 | 2009 | 144 | 0.020 |
Why?
|
Lymphocytes | 1 | 2017 | 2592 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2635 | 0.020 |
Why?
|
Threonine | 1 | 2010 | 271 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1436 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3668 | 0.020 |
Why?
|
Binding Sites | 2 | 2010 | 6028 | 0.020 |
Why?
|
Adsorption | 1 | 2009 | 195 | 0.020 |
Why?
|
Income | 1 | 2017 | 1864 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1800 | 0.020 |
Why?
|
Psychometrics | 1 | 2018 | 3005 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3781 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3510 | 0.020 |
Why?
|
Chickens | 1 | 2010 | 855 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2009 | 265 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2024 | 5594 | 0.020 |
Why?
|
Weight Loss | 1 | 2019 | 2649 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4377 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6479 | 0.020 |
Why?
|
Water | 1 | 2014 | 1397 | 0.020 |
Why?
|
Alanine | 1 | 2010 | 584 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6743 | 0.020 |
Why?
|
Pyridines | 1 | 2019 | 2862 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6507 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39077 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6358 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4239 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5172 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1179 | 0.020 |
Why?
|
Aging | 1 | 2023 | 8582 | 0.010 |
Why?
|
Fimbriae Proteins | 1 | 2004 | 132 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 40980 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5396 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10457 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7580 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9701 | 0.010 |
Why?
|
Primary Health Care | 1 | 2019 | 4621 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11008 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 5919 | 0.010 |
Why?
|
Coronary Disease | 1 | 2017 | 5992 | 0.010 |
Why?
|
Family Health | 1 | 2007 | 1260 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2004 | 2560 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9207 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10196 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12455 | 0.010 |
Why?
|
Exercise | 1 | 2017 | 5746 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13154 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16443 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6509 | 0.010 |
Why?
|
Escherichia coli Proteins | 1 | 2004 | 1051 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19901 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10629 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15634 | 0.010 |
Why?
|
Infant | 1 | 2016 | 35675 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 41660 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2015 | 15438 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11884 | 0.010 |
Why?
|
Child | 1 | 2016 | 79004 | 0.000 |
Why?
|
Mutation | 1 | 2004 | 29706 | 0.000 |
Why?
|